©2011 Baishideng Publishing Group Co.
World J Cardiol. Dec 26, 2011; 3(12): 383-387
Published online Dec 26, 2011. doi: 10.4330/wjc.v3.i12.383
Published online Dec 26, 2011. doi: 10.4330/wjc.v3.i12.383
Table 1 European countries included in the PubMed database analysis performed February 2011
| Western Europe | Eastern Europe and Russia |
| Andorra | Albania |
| Austria | Armenia |
| Belgium | Azerbaijan |
| Cyprus | Bosnia-Herzegovina |
| Denmark | Bulgaria |
| Finland | Croatia |
| France | Czech Republic |
| Germany | Estonia |
| Gibraltar | Hungary |
| Great Britain | Latvia |
| Greece | Lithuania |
| Iceland | Moldova |
| Ireland | Montenegro |
| Italy | Poland |
| Liechtenstein | Republic of Belarus |
| Luxembourg | Republic of Georgia |
| Malta | Republic of Macedonia |
| Monaco | Romania |
| Netherlands | Russia |
| Norway | Serbia |
| Portugal | Slovakia |
| San Marino | Slovenia |
| Scotland | Ukraine |
| Spain | Yugoslavia |
| Sweden | |
| Switzerland | |
| Wales |
- Citation: Jahangir E, Comandé D, Rubinstein A. Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention. World J Cardiol 2011; 3(12): 383-387
- URL: https://www.wjgnet.com/1949-8462/full/v3/i12/383.htm
- DOI: https://dx.doi.org/10.4330/wjc.v3.i12.383